期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (4)
Blood samples were collected alongside with routine blood cultures (BC) from patients with suspected sepsis, to evaluate the prevalence of different c......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (5)
This study is an economic analysis seeking to examine cost savings that may be accrued from usage of oral linezolid in place of OPAT IV daptomycin in ......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (6)
Ceftriaxone sodium for injection is an antibiotic used clinically. Here, we developed a strategy for evaluating the consistency of ceftriaxone sodium ......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; ()
Countless efforts have been made to prevent and suppress the formation and spread of melanoma. Natural astaxanthin (AST; extracted from the alga Haema......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; ()
Sonic hedgehog (SHH) medulloblastoma etiology is associated with the SHH molecular pathway activation at different levels. We investigated the effect ......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; ()
This article aimed to investigate the correlations among SKA3 expression and prognosis, clinical relevance, tumor immunity, and RNA-binding protein (R......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (2)
Cisplatin, as a first-line chemotherapy drug for advanced wild-type epidermal growth factor receptor (wtEGFR) non-small cell lung cancer (NSCLC), ofte......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (2)
Our aim was to explore and summarize available cases of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) suspected to be associated......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (2)
Cisplatin (DDP) is first-line management for ovarian cancer (OC). Previous data have suggested that circular RNA_0007841 (circ_0007841) regulates OC p......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (2)
Chemotherapy or involvement in a clinical trial remain the standard treatment for patients with EGFR mutant non-small cell lung cancer who have diseas......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (3)
Echinocandins form a new drug class for the treatment of Pneumocystis pneumonia (PCP), but their efficacies have not been confirmed. The objective of ......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (4)
Breast cancer is the most frequent malignancy worldwide, with immunotherapy and targeted therapy being key strategies to improving the prognosis. We d......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (5)
The aim of this study was to investigate the safety and efficacy of anti-programmed death ligand 1 (PD-L1) immunotherapy plus chemoradiotherapy for pa......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; 35 (8)
The objective of this study was to evaluate the efficacy of various micafungin dosing regimens against Candida spp. in pediatric patients undergoing h......
期刊： JOURNAL OF CHEMOTHERAPY, 2023; ()
The aim of our study was to evaluate the association between increased splenic volume (SV) and liver fibrosis indices in colon cancer patients receivi......
